(Q38629669)

English

AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

4 September 2017

AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective (English)

1 reference

stated in

Europe PubMed Central

4 September 2017

Asier Unciti-Broceta

3

0 references

Valerie G Brunton

series ordinal

2

object named as

Valerie G Brunton

1 reference

stated in

Europe PubMed Central

4 September 2017

Samuel H Myers

1

1 reference

stated in

Europe PubMed Central

PubMed ID

26555154

retrieved

4 September 2017

language of work or name

English

0 references

publication date

10 November 2015

1 reference

stated in

Europe PubMed Central

4 September 2017

Journal of Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

4 September 2017

59

1 reference

stated in

Europe PubMed Central

4 September 2017

8

1 reference

stated in

Europe PubMed Central

4 September 2017

3593-3608

1 reference

stated in

Europe PubMed Central

4 September 2017

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG.2330

Identifiers

DOI

10.1021/ACS.JMEDCHEM.5B01273

1 reference

stated in

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

PubMed ID

26555154

retrieved

4 September 2017

(Q38629669)

AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)